The significance of benign endometrial cells in cervicovaginal smears

Advances in Anatomic Pathology

Volumn 12, Issue 5, 2005, Pages 274-287

  Fadare, Oluwole ^a,c   Ghofrani, Mohiedean ^a   Chacho, Mary S ^a   Parkash, Vinita ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL OF SAINT RAPHAEL   (United States)

^c WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Benign endometrial cells; Bethesda 2001; Cervicovaginal smear; Menstrual cycle; Normal endometrial cells; Papanicolaou (pap) smear

Indexed keywords

ESTROGEN; TAMOXIFEN;

AGING; CANCER RISK; CONTRACEPTION; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; FOLLOW UP; HISTIOCYTE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; LEIOMYOMA; MENSTRUAL CYCLE; NONHUMAN; ORAL CONTRACEPTION; PAPANICOLAOU TEST; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VAGINA BLEEDING;

ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENSTRUAL CYCLE; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; VAGINAL SMEARS;

EID: 26844436386     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/01.pap.0000184174.76221.eb     Document Type: Review

References (86)

1. Adami H-O, Ponten J, Sparen P, et al. Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening, 1960-1984. Cancer. 1994;73:140-147.
2. Benedet JL, Anderson GH, Matistic JP. A comprehensive program for cervical cancer detection and management. Am J Obstet Gynecol. 1992; 166:1254-1259.
3. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and tragedy. JAMA. 1989;261:737-743.
4. van de Graaf Y, Vooijs GP, Zielhuis GA. Cervical screening revisited. Acta Cytol. 1990;34:366-372.
5. Devesa SS, Young JL, Brinton LA, et al. Recent trends in cervix uteri cancer. Cancer. 1989;64:2184-2190.
6. Wingo PA, Cardinez CJ, Landis SH, et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer. 2003;97:3133-3275.
7. Jemal A, Tiwari RC, Murray T, et al. Cancer Statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
8. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for early detection of cancer, 2004. CA Cancer J Clin. 2004;54:41-52.
9. American College of Obstetricians and Gynecologists. Routine cancer screening. ACOG opinion, no. 185. Washington, D.C., 1997.
10. Koss LG. Proliferative disorders and carcinoma of the endometrium. In: Koss LG, ed. Diagnostic Cytology and Its Histopathologic Bases. 3rd ed. Philadelphia: Lippincott; 1979:412-450.
11. Ng ABP. The cellular detection of endometrial carcinoma and its precursors. Gynecol Oncol. 1974;2:162-179.
12. Burk JR, Lehman HF, Wolf FS. Inadequacy of papanicolaou smears in the detection of endometrial cancer. N Engl J Med. 1974;291:191-192.
13. Gusberg SB, Milano C. Detection of endometrial cancer and its precursors. Cancer. 1981;47:1173-1175.
14. Levine L, Lucci JA 3rd, Dinh TV. Atypical glandular cells: new Bethesda Terminology and Management Guidelines. Obstet Gynecol Surv. 2003;58: 399-406.
15. Cangiarella JF, Chhieng DC. Atypical glandular cells - an update. Diagn Cytopathol. 2003;29:271-279.
16. Chhieng DC, Cangiarella JF. Atypical glandular cells. Clin Lab Med. 2003;23:633-657.
17. Jeng CJ, Liang HS, Wang TY, et al. Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening. Int J Gynecol Cancer. 2003;13:518-521.
18. Pundel JP. Are degenerative cell changes in endometrial cells due to inadequate preparation technique of smears? Acta Cytol. 1958;2:588-590.
19. Moriaty AT, Cibas ES. Endometrial cells: the how and when of reporting. In: Solomon D, Nayar R, eds. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes. 2nd ed. New York: Springer-Verlag; 2004:57-65.
20. Ng ABP, Reagan JW. Normal endometrial cells and their significance in the detection of benign and malignant endometrial lesions. In: Wied GL, Keebler CM, Koss LG, et al, eds. Compendium on Diagnostic Cytology. Chicago: Tutorials of Cytology; 1992:119-123.
21. Kurman RJ, Solomon D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses: Definitions, Criteria, and Explanatory Notes for Terminology and Specimen Adequacy. New York: Springer-Verlag; 1994.
22. DeMay M. Practical Principles of cytopathology. Chicago: ASCP Press; 1999.
23. Takahashi M. Female genital tract. In: Takahashi M, ed. Color Atlas of Cancer Cytology. 3rd ed. Tokyo: Igaku-Shoin; 2000:47-135.
24. Meisels A, Morin C. The normal uterus. In: Meisels A, Morin C, eds. Cytopathology of the Uterus. Chicago: ASCP Press; 1997:29-48.
25. Koss LG. Proliferative disorders and carcinoma of the endometrium. In: Koss LG, ed. Diagnostic Cytology and Its Histopathologic Bases, Vol 1. 4th ed. Philadelphia: Lippincott; 1992:535-587.
26. Chang BS, Pinkus GS, Cibas ES. Exfoliated endometrial cells in cervical cytologic preparations are derived from endometrial stroma and glands. Mod Pathol. 2004;17:63A. Abstract.
27. Ng ABP, Reagan JW, Hawliczek S, et al. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol. 1974;18:356-361.
28. DeMay RM. Hyperchromatic crowded groups: pitfalls in papa smear diagnosis. Am J Clin Pathol. 2000;114(suppl):S36-S43.
29. Bakos O, Lundkvist O, Bergh T. Transvaginal sonographic evaluation of endometrial growth and texture in spontaneous ovulatory cycles - a descriptive study. Hum Reprod. 1993;8:799-806.
30. Smith SK. The menstrual cycle. In: Glasser SR, Aplin JD, Giudice LC, Tabibzadeh S., eds. The Endometrium. London: Taylor and Francis; 2002: 73-85.
31. Zoma WD, Cedars MI. Endometrial imaging. In: Glasser SR, Aplin JD, Giudice LC, Tabibzadeh S., eds. The Endometrium. London: Taylor and Francis; 2002:642-651.
32. Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab. 1996; 81:4144-4147.
33. Hopwood D, Levinson DA. Atrophy and apoptosis in the cyclical human endometrium. J Pathol. 1976;119:159-166.
34. Okulicz WC. Regeneration. In: Glasser SR, Aplin JD, Giudice LC, Tabibzadeh S., eds. The Endometrium. London: Taylor and Francis; 2002: 110-120.
35. Simon C, Caballero-Campo P, Galan A, et al. The endometrial epithelium. In: Glasser SR, Aplin JD, Giudice LC, Tabibzadeh S., eds. The Endometrium. London: Taylor and Francis; 2002:194-207.
36. Pollard JW, Pacey J, Cheng SVY, et al. Estrogens and cell death in murine uterine luminal epithelium. Cell Tissue Res. 1987;249:533-540.
37. Sandow BA, West NB, Norman RL, et al. Hormonal control of apoptosis in hamster uterine luminal epithelium. Am J Anat. 1979;156:15-36.
38. Potter SW, Gaza G, Morris JE. Estradiol induces E-Cadherin degradation in mouse uterine epithelium during the estrous cycle and early pregnancy. J Cell Physiol. 1996;169:1-14.
39. Liu W, Barrow MJ, Spitler MF, et al. Normal exfoliation of endometrial cells in premenopausal women. Acta Cytol. 1963;7:211-214.
40. Vooijs GP, van der Graaf Y, Vooijs MA. The presence of endometrial cells in cervical smears in relation to the day of the menstrual cycle and the method of contraception. Acta Cytol. 1987;31:427-133.
41. Kerpsack JT, Finana MA, Kline RC. Correlation between endometrial cells on papanicolaou smear and endometrial carcinoma. South Med J. 1998;91:749-752.
42. Gondos B, King EB. Significance of endometrial cells in cervicovaginal smears. Ann Clin Lab Sci. 1977;7:486-490.
43. Sarode VR, Rader AE, Rose PG, Rodriguez M, Abdul-Karim FW. Significance of cytologically normal endometrial cells in cervical smears from postmenopausal women. Acta Cytol. 2001;45:153-156.
44. Karim BO, Burroughs FH, Rosenthal DL, Ali SZ. Endometrial-type cells in cervico-vaginal smears: clinical significance and cytopathologic correlates. Diagn Cytopathol. 2002;26:123-127.
45. Montz FJ. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy. Gynecol Oncol. 2001;81:33-39.
46. Gomez-Fernandez CR, Ganjei-Azar P, Capote-Dishaw J, et al. Reporting normal endometrial cells in pap smears: an outcome appraisal. Gynecol Oncol. 1999;74:381-384.
47. Gomez-Fernandez CR, Ganjei-Azar P, Behshid K, et al. Normal endometrial cells in papanicolaou smears: prevalence in women with and without endometrial disease. Obstet Gynecol. 2000;96:874-878.
48. Doornewaard H, Sie-Go DM, Woudt JM, et al. The significance of endometrial cells in the cervical smear. Ned Tijdschr Geneeskd. 1993;137: 868-872. Dutch.
49. Mount SL, Wegner EK, Eltabbakh GH, et al. Significant increase of benign endometrial cells on papanicolaou smears in women using hormone replacement therapy. Obstet Gynecol. 2002;100:445-450.
50. Ashfaq R, Sharma S, Dulley T, et al. Clinical relevance of benign endometrial cells in postmenopausal women. Diagn Cytopathol. 2001;25: 235-238.
51. Gray JA, Nguyen GK. Cytologic detection of endometrial pathology by pap smears. Diagn Cytopathol. 1999;20:181-182.
52. Chang A, Sandweiss L, Bose S. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women. Gynecol Oncol. 2001;80:37-43.
53. Yancey M, Magelssen D, Demaurez A, et al. Classification of endometrial cells on cervical cytology. Obstet Gynecol. 1990;76:1000-1005.
54. Cherkis RC, Patten SF Jr, Andrews TJ, et al. Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol. 1988;71: 242-244.
55. Brogi E, Tambouret R, Bell DA. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women. Cancer. 2002;96:60-66.
56. Wu HH, Schuetz M, Cramer HM. Benign endometrial cells in postmenopausal women: a study of 61 cases with histologic follow-up. Acta Cytol. 1999;43:912. Abstract.
57. Van den Bosch T, Vandendael A, Wranz PA, et al. Cervical cytology in menopausal women at high risk for endometrial disease. Eur J Cancer Prev. 1998;7:149-152.
58. de Peralta-Venturino MN, Purslow MJ, Kini SR. Endometrial cells of the "lower uterine segment" (LUS) in cervical smears obtained by endocervical brushings: a source of potential diagnostic pitfall. Diagn Cytopathol. 1995;12:263-268.
59. Henry MR. The Bethesda System 2001: an update of new terminology for gynecologic cytology. Clin Lab Med. 2003;23:585-603.
60. Zucker PK, Kasdon EJ, Feldstein ML. The validity of pap smear parameters as predictors of endometrial pathology in menopausal women. Cancer. 1985;56:2256-2263.
61. Astrup K, Olivarius NDF. Frequency of spontaneously occurring postmenopausal bleeding in the general population. Acta Obstet Gynecol Scand. 2004;83:203-207.
62. Bachmann LM, Riet GT, Clark TJ, et al. Probability analysis for diagnosis of endometrial hyperplasia and cancer in postmenopausal bleeding: an approach for a rational diagnostic workup. Acta Obstet Gynecol Scand. 2003;82:564-569.
63. Archer DF, Pickar JH, Bottiglioni F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group. Obstet Gynecol. 1994;83:686-692.
64. Barnabei VM, Grady D, Stovall DW, et al. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol. 2002;100:1209-1218.
65. Mossa B, Imperato F, Marziani R, et al. Hormonal replacement therapy and evaluation of intrauterine pathology in postmenopausal women: a ten-year study. Eur J Gynaecol Oncol. 2003;24:507-512.
66. Simsir A, Carter W, Elgert P, et al. Reporting of endometrial cells in women 40 years and older. Assessing the clinical usefulness of Bethesda 2001. Am J Clin Pathol. 2005;123:571-575.
67. Opjorden SL, Caudill JL, Humphrey SK, et al. Small cells in cervical-vaginal smears of patients treated with tamoxifen. Cancer. 2001;93:23-28.
68. Yang YJ, Demoski R, Bellerdine J, et al. Tamoxifen-associated "small cells" on pap smears. Acta Cytol. 1997;41:1542-1543.
69. Nassar A, Fleisher SR, Nasuti JF. Value of histiocyte detection in pap smears for predicting endometrial pathology. An institutional experience. Acta Cytol. 2003;47:762-767.
70. Tambouret R, Bell DA, Centeno BA. Significance of histiocytes in cervical smears from peri/postmenopausal women. Diagn Cytopathol. 2001;24:271-275.
71. Nguyen TN, Bourdeau JL, Ferenczy A, et al. Clinical significance of histiocytes in the detection of endometrial adenocarcinoma and hyperplasia. Diagn Cytopathol. 1998;19:89-93.
72. Blumenfeld W, Holly EA, Mansur DL, et al. Histiocytes and the detection of endometrial adenocarcinoma. Acta Cytol. 1985;29:317-322.
73. Chhieng DC, Roberson J, Gidley J, et al. Bethesda 2001. Impact on reporting of gynecologic cytology. Acta Cytol. 2004;48:355-362.
74. Thrall MJ, Kjeldahl KS, Savik K, et al. Significance of benign endometrial cells in papanicolaou tests from women ≥40 years. Cancer Cytopathol. 2005;105:207-216.
75. Long DK, Biscotti C. An analysis of the Bethesda System 2001 guideline for reporting benign endometrial cells. Acta Cytol. 2004;48:676-677. Abstract.
76. Bean S, Connolly K, Roberson J, et al. Incidence and clinical significance of normal endometrial cells in patients 40 years and older. Acta Cytol. 2004;48:677. Abstract.
77. Papillo JL, Harmon ML, Mount SL, et al. Reporting of endometrial cells in women 40-50 results in increased endometrial biopsies with low yield. Acta Cytol. 2004;48:677-678. Abstract.
78. Ely KA, Bregman S, Arnott CK. Clinical significance of reporting endometrial cells in patients over the age of 40 and its influence on the decision to biopsy. Acta Cytol. 2004;48:678. Abstract.
79. Saad RS, Mahdavy M, Takei H, et al. Endometrial cells in cervical specimens of women ≥40 years of age. Acta Cytol. 2004;48:678-679. Abstract.
80. Thrall MJ, Savik K, Kjeldahl K, et al. Benign endometrial cells in papanicolaou tests of women over 40 have a low predictive value for endometrial malignancy. Mod Pathol. 2005;18:79A. Abstract.
81. Kurella S, Gupta C, Mazzara PF. Clinical significance of the presence of cytologically benign endometrial cells in papanicolaou smears in women age 40 and above: experience at a community hospital. Mod Pathol. 2004; 17:73A. Abstract.
82. Chang BS, Browne TJ, Cibas ES, et al. Benign-appearing endometrial cells (BEMC) in women ≥40 years age: did Bethesda revision influence the biopsy rate and the detection of EM cancer? Mod Pathol. 2004;17:64A. Abstract.
83. Carter W, Elgert P, Simsir A, et al. Clinical significance of reporting endometrial cells in patients over the age forty: assessing modifications of Bethesda 2001. Mod Pathol. 2004;17:63A. Abstract.
84. Xu C, Pisharodi L. Clinical significance of endometrial cells in women ≥40 years of age in pap smear: analysis of 817 cases. Mod Pathol. 2004; 17:87A. Abstract.
85. Petcu EB, Assaad MW, Hornish M, et al. Endometrial biopsy results in patients with endometrial cells on pap test utilizing Bethesda System 2001. Mod Pathol. 2004;17:78A. Abstract.
86. Papillio JL, St John TL. The effect of Bethesda 2001 on laboratory statistics. Acta Cytol. 2002;46:923. Abstract.